Literature DB >> 26876615

EZH2, an on-off valve in signal network of tumor cells.

Shanshan Sun1, Feng Yu2, Lun Zhang3, Xuan Zhou4.   

Abstract

Enhancer Zeste 2 (EZH2) is a histone methyltransferase catalyzing histone H3K27me3 to mediate gene silence. It is implicated in governing various biological behaviors of human malignancies. In this review, we over-review EZH2 serves as an "on-off valve"--not only as a critical epigenetic repressor, but as a brand-new activator for specific downstream targets as well. Time and space it "switching on-off" depends on the context and its cellular type. Moreover, EZH2 could act as a Tumor-Defender under certain circumstances. Moreover, the "Mutual-Inhibition" relationship between EZH2 and microRNAs is elaborated. In addition, we focus on different functions of phosphorylatied EZH2 in tumor cells. Finally, EZH2 inhibitors are summarized and newly-discovered strategies of targeting-EZH2 treatment are prospected.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Double facet; EZH2; Histone modulation; Signaling; Tumor

Mesh:

Substances:

Year:  2016        PMID: 26876615     DOI: 10.1016/j.cellsig.2016.02.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.

Authors:  M V Bais
Journal:  J Dent Res       Date:  2019-01-07       Impact factor: 6.116

2.  Expression of EZH2 and P53 and their correlation in ovarian cancer tissues.

Authors:  Li Zhai; Wen-Lin Tai; Yu-Qing Pan; Jian-Bo Luo; Li Ma; Ya-Ting Zheng; Meng-Yue Guo; Xi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

3.  Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

Authors:  Venkatrao Vantaku; Vasanta Putluri; David A Bader; Suman Maity; Jing Ma; James M Arnold; Kimal Rajapakshe; Sri Ramya Donepudi; Friedrich-Carl von Rundstedt; Vaishnavi Devarakonda; Julien Dubrulle; Balasubramanyam Karanam; Sean E McGuire; Fabio Stossi; Abhinav K Jain; Cristian Coarfa; Qi Cao; Andrew G Sikora; Hugo Villanueva; Shyam M Kavuri; Yair Lotan; Arun Sreekumar; Nagireddy Putluri
Journal:  Oncogene       Date:  2019-08-05       Impact factor: 9.867

4.  Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis.

Authors:  Wenbo Ma; Bart Tummers; Edith M G van Esch; Renske Goedemans; Cornelis J M Melief; Craig Meyers; Judith M Boer; Sjoerd H van der Burg
Journal:  Front Immunol       Date:  2016-11-22       Impact factor: 7.561

5.  EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.

Authors:  Xiaoqing Yi; Jianfeng Guo; Jing Guo; Si Sun; Ping Yang; Junjie Wang; Yuan Li; Lisha Xie; Jing Cai; Zehua Wang
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

6.  Long intergenic noncoding RNA 00673 promotes non-small-cell lung cancer metastasis by binding with EZH2 and causing epigenetic silencing of HOXA5.

Authors:  Chenhui Ma; Guannan Wu; Qingqing Zhu; Hongbing Liu; Yanwen Yao; Dongmei Yuan; Yafang Liu; Tangfeng Lv; Yong Song
Journal:  Oncotarget       Date:  2017-05-16

7.  EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells.

Authors:  Ming-Quan Sha; Xiao-Li Zhao; Liang Li; Li-Hui Li; Yi Li; Tian-Geng Dong; Wei-Xin Niu; Li-Jun Jia; Rong-Guang Shao; Yong-Su Zhen; Zhen Wang
Journal:  Cell Death Dis       Date:  2016-11-24       Impact factor: 8.469

8.  FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3.

Authors:  Xifeng Xiong; Xudong Lai; Jinli Zhang; Qingqi Meng; Pengzhen Wang; Shengnan Qin; Wei Liu; Yongxuan Wang; Zhuo Yao; Di Wang; Xiaojian Li; Zhihe Liu; Haixiong Miao
Journal:  Biosci Rep       Date:  2022-09-30       Impact factor: 3.976

9.  Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

Authors:  Sunny Malhotra; Luisa M Villar; Carme Costa; Luciana Midaglia; Marta Cubedo; Silvia Medina; Nicolás Fissolo; Jordi Río; Joaquín Castilló; José C Álvarez-Cermeño; Alex Sánchez; Xavier Montalban; Manuel Comabella
Journal:  J Neuroinflammation       Date:  2018-10-26       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.